Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

Cancer immunotherapy (CIT) initiates or enhances the host immune response against cancer. Following decades of development, patients with previously few therapeutic options may now benefit from CIT. Although the quantitative clinical pharmacology (qCP) of previous classes of anticancer drugs has mat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:CPT Pharmacometrics Syst Pharmacol
Hoofdauteurs: Stroh, M, Carlile, DJ, Li, C-C, Wagg, J, Ribba, B, Ramanujan, S, Jin, J, Xu, J, Charoin, J-E, Xhu, Z-X, Morcos, PN, Davis, JD, Phipps, A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Ltd 2015
Onderwerpen:
Perspective
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592528/
https://ncbi.nlm.nih.gov/pubmed/26451328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12014
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items